CHINA has overturned Pfizer's patent for the blockbuster male impotence drug Viagra.The move has plunged the pharmaceutical world into uncertainty over the most populous country's willingness to provide adequate protection for intellectual property.The ruling paves the way for a string of generic versions of the popular drug,and sets a worrying precedent for the future protection of other blockbuster drugs in one of the world's largest potential markets.
展开▼
